Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Completed 65Unknown 26Terminated 23Recruiting 20Active not recruiting 15Not yet recruiting 10Withdrawn 4Available 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 3Genitourinary 1

Conditions

Carcinoma, Hepatocellular 2Pancreatic Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma 1

Interventions

Cyclophosphamide 129Cisplatin 119Radiotherapy 115pembrolizumab 111Carboplatin 97Paclitaxel 96Gemcitabine 96Magnetic Resonance Spectroscopy 80Nivolumab 76Bevacizumab 76Fluorouracil 74Dexamethasone 73Radiosurgery 66Docetaxel 59Rituximab 58Leucovorin 57Oxaliplatin 55Capecitabine 55Biopsy 53Doxorubicin 52fludarabine 51Drug Therapy 45durvalumab 44Cytarabine 44Etoposide 42fludarabine phosphate 40Pemetrexed 40Radiation 39atezolizumab 36Surveys and Questionnaires 36

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × Mitomycin × Clear all
NCT04006691 2020-05-07

Retreatment

UroGen Pharma Ltd.

Phase 3 Withdrawn
Genitourinary

Carcinoma, Carcinoma, Transitional Cell

NCT00386399 2018-07-12

Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 Gene

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Withdrawn
Gastrointestinal

Pancreatic Neoplasms

NCT01953406 2016-04-27

The Efficacy of 5-fluorouracil/Mitomycin for the Patients With Pulmonary Metastasis of Hepatocellular Carcinoma

Seoul National University Hospital

Phase 2 Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular

NCT01327521 2012-06-11

Transarterial Chemoembolization vs CyberKnife for Recurrent Hepatocellular Carcinoma

Stanford University

Phase 3 Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡